Goleta, CA – According to filings with the U.S. Securities and Exchange Commission, Serimmune is raising $23,312,065.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Patrick Daugherty played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Serimmune

Serimmune is an immune intelligence company focused on identifying and exploiting the universe of relationships between antibodies and antigens. Our proprietary technology provides a holistic view of the functional antibody repertoire to identify diverse immunogenic factors in disease and health. The company’s Serum Epitope Repertoire Analysis (SERA) technology platform combines a novel, random bacterial display peptide library with next generation sequencing, machine learning, and custom bioinformatics to reveal the many diverse antigens stimulating immunity. Serimmune’s human immunity map is a growing database that can be interrogated to fuel the development of multiplex diagnostics, vaccines and therapeutics.

To learn more about Serimmune, visit http://www.serimmune.com/

Contact:
Patrick Daugherty, Chief Executive Officer
805-451-5083
https://www.linkedin.com/in/patrick-daugherty-0b5aaa22/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved